MENU
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genmab A/S ADS (GMAB) Earnings Date & Reports
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
A.I. Advisor
published Earnings
GMAB is expected to report earnings to fall 22.61% to 37 cents per share on November 05
Q3'26
Est.
$0.38
Q2'26
Beat
by $0.15
Q1'26
Missed
by $0.09
Q4'25
Beat
by $14.94
Q3'25
Beat
by $0.18
The last earnings report on August 06 showed earnings per share of 49 cents, beating the estimate of 34 cents. With 2.34M shares outstanding, the current market capitalization sits at 24.33B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.
Industry Biotechnology
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2819
Web
https://www.genmab.com